Claus Braestrup - Evotec SE Member of the Supervisory Board

EVOTF Stock  USD 10.18  3.65  26.39%   

Executive

Dr. Claus T. Braestrup, M.D., was Independent Member of the Supervisory Board of Evotec AG since June 12, 2013. He is Member of the Audit Committee at the Company. During his career, he gained experience from publicly traded international pharmaceutical companies as well as scientific and drug discovery qualifications. From 2003 to 2008, he served as President and CEO at H. Lundbeck AS, where he was head of research and development from 1998 to 2003. Previously, he served as head of preclinical drug research at Schering AG from 1994 to 1998, at Novo Nordisk AS as president of the Diabetes Care Division, President of its CNS Division and Vice President of pharmaceutical research and at Ferrosan AS as scientist in drug discovery from 1978 to 1984. He serves as Chairman of the Board of Saniona AB and as Member of the Board of Bavarian Nordic AS, Kastan ApS and Evolva SA. He holds a Masters degree in Chemical Engineering and is MS in Biochemistry. He is Doctor of Medical Science and former Adjunct Professor in Neuroscience at the University of Copenhagen. since 2013.
Age 72
Tenure 11 years
Phone49 40 560 81 0
Webhttps://www.evotec.com

Evotec SE Management Efficiency

Evotec SE's management efficiency ratios could be used to measure how well Evotec SE manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 326.34 M in total debt with debt to equity ratio (D/E) of 0.38, which is about average as compared to similar companies. Evotec SE has a current ratio of 3.5, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Evotec SE until it has trouble settling it off, either with new capital or with free cash flow. So, Evotec SE's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Evotec SE sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Evotec to invest in growth at high rates of return. When we think about Evotec SE's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Bart DunnCollegium Pharmaceutical
N/A
Eiry RobertsNeurocrine Biosciences
54
Malcolm LloydSmithNeurocrine Biosciences
62
Margarida DuarteDeciphera Pharmaceuticals LLC
N/A
Julie CookeNeurocrine Biosciences
58
Jane SorensenNeurocrine Biosciences
N/A
Michael MDIronwood Pharmaceuticals
64
Craig MDAlkermes Plc
56
Jerad SeurerAvadel Pharmaceuticals PLC
N/A
Matthew AbernethyNeurocrine Biosciences
44
Max ReinhardtPacira Pharmaceuticals
53
Christopher MDCollegium Pharmaceutical
N/A
Mark ElrodAvadel Pharmaceuticals PLC
N/A
Dashyant DhanakDeciphera Pharmaceuticals LLC
63
Roy WinstonPacira Pharmaceuticals
57
Selina ZhangHUTCHMED DRC
N/A
David NgHUTCHMED DRC
N/A
Peter NormanAlkermes Plc
N/A
Esq IIIPacira Pharmaceuticals
50
Samuel ParisiAlkermes Plc
49
DO EllisPacira Pharmaceuticals
53
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany. EVOTEC SE operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4521 people. Evotec SE [EVOTF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Evotec SE Leadership Team

Elected by the shareholders, the Evotec SE's board of directors comprises two types of representatives: Evotec SE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Evotec. The board's role is to monitor Evotec SE's management team and ensure that shareholders' interests are well served. Evotec SE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Evotec SE's outside directors are responsible for providing unbiased perspectives on the board's policies.
Matthias Evers, Chief Board
Werner Lanthaler, President of the Management Board, CEO
Claus Braestrup, Member of the Supervisory Board
Michael Shalmi, Member of the Supervisory Board
Monika Conradt, Global HR
Christian Dargel, EVP Compliance
Mario Polywka, COO and Member of Management Board
Anja Bosler, Principal Accounting
Mary Tanner, Member of the Supervisory Board
Volker Braun, VP ESG
Roland Oetker, Deputy Chairman of the Supervisory Board
Andreas Pinkwart, Member of the Supervisory Board
Paul Herrling, Member of the Supervisory Board
Colin Bond, CFO and Member of Management Board
Cord Dohrmann, Chief Scientific Officer and Member of Management Board
Iris LoewFriedrich, Member of the Supervisory Board
Bernd Hirsch, Member of the Supervisory Board
Enno Spillner, CFO, Member of the Management Board
Elaine Sullivan, Member of the Supervisory Board
Gabriele Hansen, Vice President Corporate Communications & Investor Relations
MBA MBA, Chairman CEO
Craig Johnstone, COO, Member of the Management Board
Wolfgang Plischke, Chairman of the Supervisory Board

Evotec Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Evotec SE a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Evotec SE

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evotec SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will appreciate offsetting losses from the drop in the long position's value.

Moving against Evotec Pink Sheet

  0.84TEVA Teva PharmaceuticalPairCorr
  0.42LRDG Lord Global CorpPairCorr
The ability to find closely correlated positions to Evotec SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evotec SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evotec SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evotec SE to buy it.
The correlation of Evotec SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evotec SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evotec SE moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evotec SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Evotec Pink Sheet analysis

When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.